Mettler-Toledo International Inc (MTD)vsNatera Inc (NTRA)
MTD
Mettler-Toledo International Inc
$1,293.52
+1.01%
HEALTHCARE · Cap: $26.56B
NTRA
Natera Inc
$328.93
+0.86%
HEALTHCARE · Cap: $46.72B
Smart Verdict
WallStSmart Research — data-driven comparison
Mettler-Toledo International Inc generates 53% more annual revenue ($4.13B vs $2.71B). MTD leads profitability with a 21.9% profit margin vs -7.1%. MTD earns a higher WallStSmart Score of 64/100 (C+).
MTD
Buy64
out of 100
Grade: C+
NTRA
Avoid31
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 31.2%
Safe zone — low bankruptcy risk
Every $100 of equity generates 30 in profit
Keeps 22 of every $100 in revenue as profit
Revenue surging 37.7% year-over-year
Conservative balance sheet, low leverage
Areas to Watch
Expensive relative to growth rate
Moderate valuation
4.5% revenue growth
Weak financial health signals
0.0% earnings growth
Weak financial health signals
Trading at 25.9x book value
ROE of -10.6% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : MTD
The strongest argument for MTD centers on Operating Margin, Altman Z-Score, Return on Equity. Profitability is solid with margins at 21.9% and operating margin at 31.2%.
Bull Case : NTRA
The strongest argument for NTRA centers on Revenue Growth, Debt/Equity. Revenue growth of 37.7% demonstrates continued momentum.
Bear Case : MTD
The primary concerns for MTD are PEG Ratio, P/E Ratio, Revenue Growth. Debt-to-equity of 164.70 is elevated, increasing financial risk.
Bear Case : NTRA
The primary concerns for NTRA are EPS Growth, Piotroski F-Score, Price/Book.
Key Dynamics to Monitor
MTD profiles as a value stock while NTRA is a hypergrowth play — different risk/reward profiles.
NTRA carries more volatility with a beta of 1.53 — expect wider price swings.
NTRA is growing revenue faster at 37.7% — sustainability is the question.
MTD generates stronger free cash flow (283M), providing more financial flexibility.
Bottom Line
MTD scores higher overall (64/100 vs 31/100), backed by strong 21.9% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Mettler-Toledo International Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Mettler Toledo (NYSE: MTD) is a multinational manufacturer of scales and analytical instruments. It is the largest provider of weighing instruments for use in laboratory, industrial, and food retailing applications. The company also provides various analytical instruments, process analytics instruments, and end-of-line inspection systems.
Visit Website →Natera Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Natera, Inc., a diagnostic company, develops and markets molecular testing services globally. The company is headquartered in San Carlos, California.
Compare with Other DIAGNOSTICS & RESEARCH Stocks
Want to dig deeper into these stocks?